http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006293384-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_754689f8bd239204e849ff9a0bcee63e |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-07 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21 |
filingDate | 2004-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1607e7b950b65b523abde142d68660c |
publicationDate | 2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2006293384-A1 |
titleOfInvention | Isethionyl nitrates and compounds thereof |
abstract | The present invention provides nitric ester compound corresponding to the formula: n n nin which the cation M is selected from the group consisting of: hydrogen, alkali metal cations, alkaline earth metal cations, Group III metal cations, transition metal cations, ammonium ions (including organic-substituted ammonium cations), including mixtures of any two or more of the foregoing; R 1 and R 2 are each independently selected from the group consisting of: hydrogen and a C 1 to C 6 hydrocarbyl group; n represents the valence of the cation, including the integers 1, 2, and 3; X is an anion selected from the group consisting of: fluoride, chloride, bromide, iodide, nitrate, nitrite, phosphate, phosphate, monohydrogen phosphate, taurate, dihydrogen phosphate, monohydrogen sulfate, sulfate, carbonate, bicarbonate, hydroxide, carboxylate, dicarboxylate and polycarboxylate anions; y is the valence of the anionic species X and may be 1, 2, or 3; p may be any integer including 1, 2, and 3, subject to the proviso that p is not greater than n; q may be any integer selected from the group consisting of: 0, 1, 2, 3 subject to the proviso that q is not greater than n−p, and further subject to the provisos that the sum of p plus the product of (y times q) equals the valence n of the cation M and that p is not equal to zero. The compounds of the invention are useful as coronary vasodilators. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011152651-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9173579-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512408-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11197617-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8423108-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7678057-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103834497-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9002440-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808160-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10390767-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007088222-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568583-B2 |
priorityDate | 2004-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.